APLS icon

Apellis Pharmaceuticals

243 hedge funds and large institutions have $2.26B invested in Apellis Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 106 increasing their positions, 68 reducing their positions, and 49 closing their positions.

Holders
243
Holders Change
-11
Holders Change %
-4.33%
% of All Funds
3.26%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
43
Increased
106
Reduced
68
Closed
49
Calls
$47.3M
Puts
$9.73M
Net Calls
+$37.5M
Net Calls Change
+$30.8M
Name Market Value Shares Shares
Change
Shares
Change %
SWM
276
Spire Wealth Management
Virginia
-482 Closed
AF
277
Advisornet Financial
Minnesota
-415 Closed
BTI
278
Blue Trust Inc
Georgia
-305 Closed
SSG
279
Summit Securities Group
New York
-278 Closed
PS
280
Principal Securities
Iowa
-130 Closed
SW
281
SVB Wealth
Massachusetts
-94 Closed
SAM
282
Sherman Asset Management
California
-63 Closed
QC
283
Quent Capital
New York
-49 Closed
PWMG
284
Private Wealth Management Group
New Jersey
-42 Closed
CWC
285
Carolinas Wealth Consulting
North Carolina
-39 Closed
BIA
286
Bell Investment Advisors
California
-32 Closed
CFO
287
CVA Family Office
Colorado
-20 Closed
BF
288
BOK Financial
Oklahoma
-16 Closed
AW
289
Avion Wealth
Texas
-15 Closed
CA
290
CoreCap Advisors
Michigan
-10 Closed
HFS
291
Hantz Financial Services
Michigan
-6 Closed
CFD
292
Creative Financial Designs
Indiana
-5 Closed
LP
293
LMR Partners
United Kingdom
Nomura Asset Management
294
Nomura Asset Management
Japan
IMC Chicago
295
IMC Chicago
Illinois
Capital Fund Management (CFM)
296
Capital Fund Management (CFM)
France
LGM
297
Logos Global Management
California